Ethical implications of new genetic technologies

Developmental Medicine and Child Neurology

Volumn 54, Issue 3, 2012, Pages 196-196

  Lucassen, Anneke ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COMPARATIVE GENOMIC HYBRIDIZATION; GENE TECHNOLOGY; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENOME; HUMAN; KARYOTYPE; MEDICAL ETHICS; NOTE; PRIORITY JOURNAL;

ETHICS; GENETIC TECHNIQUES; HUMANS;

EID: 84857033974     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.04182.x     Document Type: Note

References (4)

1. House of Lords. Science and Technology Committee. 2nd Report of Session 2008-09. Genomic Medicine. Volume I: Report. London: The Stationary Office Limited, 2009. (accessed 2 November 2011).
2. Paynter NP, Chasman DI, Paré G, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 2010; 303: 631-7.
3. Wade A. Event Review: Clinically Relevant Findings in Research. BioNews 620, 2011. (accessed 2 November 2011).
4. Royal College of Physicians, Royal College of Pathologists, and British Society for Human Genetics. Consent and confidentiality in clinical genetic practice: Guidance on genetic testing and sharing genetic information, 2nd edn. A report of the Joint Committee on Medical Genetics. London: RCP, RCPath, 2011. (accessed 2 November 2011).